Oncotarget launches special collection on breast cancer

December 01, 2020

BUFFALO, NY-November 18, 2020 – Each year, an estimated 40,000+ women and men lose the battle against breast cancer in the United States. After skin cancer, breast cancer is the most commonly diagnosed cancer in women.

Oncotarget launched the new Special Collections series on the free-to-read and rigorously peer-reviewed journal's website. The first collection in this series is the Special Collection on breast cancer—which includes numerous recently published scientific papers that pertain to breast cancer research in the Oncotarget Journal.

“Special Collections are useful tools for researchers who are interested in learning from previously published studies about a specific topic,” the Oncotarget Media Office explains.

Papers included in this collection relate to new prognostic markers, risk factors, therapies, gene and protein studies, oncogenes, and other target mechanisms that may be used to treat breast cancer. This free-to-read collection is designed to be an open access resource for the medical science community to promote a better understanding of all the latest and most important breast cancer research.

“This new collection can be used as a resource to help researchers and scientists design new studies that may lead to novel breakthroughs in breast cancer treatments and therapies,” the Oncotarget Media Office said.
Read the new Oncotarget Special Collection on breast cancer.

Read a blog about this new resource.

About Oncotarget by Impact Journals:
Oncotarget is a primarily oncology-focused, world-class, peer-reviewed, open access, and weekly journal that is published every Tuesday. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases.

For media requests, please contact: media@impactjournals.com

Oncotarget | Impact Journals
Impact Journals LLC
6666 E.Quaker St. Ste. 1
Orchard Park, NY 14127

Impact Journals LLC

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.